Zhu et al.
added methyl iodide (2.00 mL, 30.0 mmol) at room tempera-
ture. The mixture was stirred at 80 °C overnight and then
concentrated in vacuo. The resulting residue was triturated
with dichloromethane (150 mL), and the organic phase was
washed with water (50 mL) and brine (50 mL) and dried over
sodium sulfate. After removal of the solvent, a yellow oily
residue was obtained (2.24 g) that was dissolved in methanol
(30 mL). To the solution was added potassium hydroxide (0.56
g, 10.0 mmol), and the mixture was heated under reflux for
3.5 h and then concentrated under reduced pressure. The
resulting oily residue was dissolved in water (40 mL) and then
acidified with concentrated hydrochloric acid to pH ) ca. 3.
The solution was then extracted with dichloromethane (3 ×
50 mL). The combined organic phase was washed with water
and brine and dried over sodium sulfate. After the solvent was
removed under reduced pressure, the crude product was
recrystallized from ethyl acetate to give 9 as a white solid (1.64
romethane was stirred at 0 °C for 3 h. After workup, the crude
product was purified by column chromatography (dichlo-
romethane) to give 12 as a white solid (0.21 g, 70%). H NMR
1
(CDCl3): δ 3.61 (s, 2 H), 3.85 (s, 3 H), 3.90 (s, 3 H), 4.06 (s, 3
H), 6.53 (s, 1 H), 7.01 (d, d, J 1 ) 0.9 Hz, J 2 ) 8.1 Hz, 1 H),
7.12 (d, t, J 1 ) 0.9 Hz, J 2 ) 8.1 Hz, 1 H), 7.45-7.51 (m, 1 H),
8.16 (s, 1 H), 8.29 (d, d, J 1 ) 2.1 Hz, J 2 ) 8.1 Hz, 1 H), 10.43
(s, 1 H). MS (ESI): m/z 303 [M + H]+. 13C NMR (CDCl3): δ
56.0, 56.1, 57.3, 97.4, 108.6, 111.4, 121.4, 122.3, 122.4, 130.0,
132.3, 132.8, 141.6, 143.1, 157.3, 162.5. IR (CHCl3): ν 3443,
3319, 1643, 1551 cm-1. Anal. Calcd for C16H18N2O4 : C, 63.56;
H, 6.00; N, 9.27. Found: C, 63.56; H, 6.02; N, 9.19.
N-[2,4-Dim eth oxy-5-(2-m eth oxyben zoyla m in o)p h en yl]-
2-m eth oxyisop h th a la m ic Acid Meth yl Ester (14). This
compound was prepared from 12 (0.91 g, 3.00 mmol) and 1320
(0.68 g, 3.00 mol) on the basis of the method described above
for 1. After workup, the crude product was purified by column
chromatography (EtOAc/CH2Cl2 1:1) to afford 14 (1.11 g) in
1
g, 78%). Mp: 154-156 °C. H NMR (CDCl3): δ 3.98 (s, 3 H),
1
4.06 (s, 3 H), 7.34 (m, 1 H), 8.10 (m, 1 H), 8.34 (m, 1 H). MS
75% yield as a pale yellow solid. H NMR (CDCl3): δ 3.94 (s,
(EI): m/z 210 [M]+.
3 H), 3.96 (s, 3 H), 3.97 (s, 3 H), 4.01 (s, 3 H), 4.06 (s, 3 H),
6.58 (s, 1 H), 7.02 (d, J ) 8.4 Hz, 1 H), 7.12 (t, J ) 7.8 Hz, 1
H), 7.32 (t, J ) 7.8 Hz, 1 H), 7.44-7.47 (m, 1 H), 7.94-7.97
(m, 1 H), 8.35-8.38 (m, 1 H), 8.43-8.46 (m, 1 H), 9.58 (s, 1
H), 10.11 (s, 1 H), 10.30 (s, 1 H). 13C NMR (CDCl3): δ 52.4,
56.0, 56.2, 56.5, 63.8, 95.4, 111.4, 115.2, 120.7, 121.5, 122.3,
124.5, 125.1, 128.6, 132.7, 134.6, 136.5, 145.8, 145.9, 157.3,
159.0, 161.7, 162.5, 166.0. IR (CHCl3): ν 3328, 3298, 1722,
1673, 1659, 1551 cm-1. MS (ESI): m/z 495 [M + H]+. Anal.
Calcd for C26H126N2O8: C, 63.15; H, 5.30; N, 5.67. Found: C,
62.77; H, 5.31; N, 5.56.
N,N′-Bis(5-a m in o-2,4-d im et h oxyp h en yl)-2-m et h oxy-
isop h th a la m id e (10). To a stirred solution of compounds 5
(0.70 g, 4.20 mmol) and 8 (0.41 g, 2.10 mmol) in tetrahydro-
furan (100 mL) were added DCC (0.95 g, 4.60 mmol) and HOBt
(0.62 g, 4.60 mmol) at room temperature. The solution was
stirred for 12 h, and then the solid was filtered off. After
workup, the crude product was purified by column chroma-
tography (CH2Cl2/MeOH 100:1) to afford compound 10 as a
1
yellow solid (0.73 g, 70%). H NMR (CDCl3): δ 3.65 (s, 4 H),
3.88 (s, 6 H), 3.92 (s, 6 H), 4.00 (s, 3 H), 6.55 (s, 2 H), 7.41 (t,
J ) 7.5 Hz, 1 H), 8.09 (s, 2 H), 8.25 (d, J ) 7.5 Hz, 2 H), 9.92
(s, 2 H). 13C NMR (CDCl3): δ 56.1, 56.9, 64.0, 97.1, 108.6, 121.5,
125.4, 128.2, 129.9, 134.9, 141.7, 143.6, 155.8, 162.1. MS
(ESI): m/z 497 [M + H]+. Anal. Calcd for C25H28N4O7: C, 60.48;
H, 5.68; N, 11.28. Found: C, 60.47; H, 5.77; N, 11.09.
N-[2,4-Dim eth oxy-5-(2-m eth oxyben zoyla m in o)p h en yl]-
2-m eth oxyisop h th a la m ic Acid (15). A suspension of 14
(0.20 g, 0.40 mmol) and lithium hydroxide hydrate (82 mg,
2.00 mmol) in a mixture of tetrahydrofuran (10 mL) and
methanol (10 mL) was stirred at 50 °C for 3 h and then cooled
to room temperature. Water (60 mL) and hydrochloric acid
(10%) were added to pH ) 6. The resulting precipitate was
filtered, washed thoroughly with water, and dried to give 15
N,N′-Bis[2,4-d im et h oxy-5-(2-m et h oxyb en zoyla m in o)-
p h en yl]-2-m eth oxyisop h th a la m id e (2) a n d N-(5-Am in o-
2,4-d im et h oxyp h en yl)-N′-[2,4-d im et h oxy-5-(2-m et h oxy-
ben zoyla m in o)p h en yl]-2-m eth oxyisop h th a la m id e (11). A
solution of 6 (0.24 g, 1.40 mmol) in dichloromethane (20 mL)
was added to a solution of 10 (0.70 g, 1.40 mmol) and
triethylamine (1 mL) in dichloromethane (20 mL) at 0 °C. The
mixture was stirred at room temperature overnight and then
concentrated in vacuo. After workup, the crude product was
purified by column chromatography (EtOAc/CH2Cl2 1:1) to
afford compounds 2 as a pale yellow solid (0.43 g, 40%) and
compound 11 as a pale yellow solid (0.18 g, 20%). Compound
1
as a pale yellow solid (0.19 g, 98%). H NMR (CDCl3): δ 3.95
(s, 3 H), 3.97 (s, 3 H), 4.07 (s, 3 H), 4.09 (s, 3 H), 6.60 (s, 1 H),
7.03 (d, J ) 8.4 Hz, 1 H), 7.13 (t, J ) 7.5 Hz, 1 H), 7.41 (t, J
) 8.1 Hz, 1 H), 7.43-7.51 (m, 1 H), 8.21-8.24 (m, 1 H), 8.35-
8.39 (m, 2 H), 9.47 (s, 1 H), 9.56 (s, 1 H), 10.34 (s, 1 H). 13C
NMR (DMSO-d6): δ 56.4, 56.5, 56.7, 63.3, 96.8, 112.6, 114.8,
119.3, 120.5, 121.2, 121.3, 124.4, 128.7, 131.2, 133.1, 133.4,
145.9, 146.8, 155.3, 157.1, 161.6, 162.6. IR (CHCl3): ν 3310,
1714, 1663, 1553 cm-1. MS (ESI): m/z 481 [M + H]+.
1
N,N′-(4,6-Dim eth oxy-m-ph en ylen e)bis[2-m eth oxy-3-[2,4-
d im e t h o x y -5-(2-m e t h o x y b e n zo y la m in o )p h e n y l]a m i-
n oca r b on yl]b en za m id e (3). A solution of compounds 15
(0.13 g, 0.28 mmol), 11 (0.18 g, 0.28 mmol), DCC (70 mg, 0.34
mmol), and HOBt (46 mg, 0.34 mmol) in dichloromethane (40
mL) was stirred at room temperature for 12 h. The solid was
filtered off, and the filtrate was concentrated under reduce
pressure. The resulting residue was subjected to column
chromatography (CH2Cl2/MeOH 1:100-1:20) to afford the
desired product as a white solid (90 mg, 30%). Mp: >250 °C.
1H NMR (CDCl3): δ 3.95 (s, 6 H), 3.97 (s, 6 H), 3.98 (s, 6 H),
4.05 (s, 6 H), 4.07 (s, 6 H), 6.57 (s, 1 H), 6.58 (s, 2 H), 7.02 (d,
J ) 7.8 Hz, 2 H), 7.13 (t, J ) 7.8 Hz, 2 H), 7.40-7.48 (m, 4 H),
8.31-8.38 (m, 6 H), 9.53 (s, 1 H), 9.55 (s, 2 H), 9.67 (s, 2 H),
9.81 (s, 2 H), 10.32 (s, 2 H). IR (CHCl3): ν 3340, 1673, 1542,
1338, 1236, 1198, 1028, 753 cm-1. HRMS (MALDI-tof): m/z
1093 [M + H]+. HRMS (MALDI-tof): calcd for C58H57N6O16
1093.3825 [M + H]+, found 1093.3837.
2. Mp: >250 °C. H NMR (CDCl3): δ 3.90 (s, 6 H), 3.95 (s, 6
H), 4.00 (s, 3 H), 4.04 (s, 6 H), 6.49 (s, 2 H), 6.99 (d, J ) 8.2
Hz, 2 H), 7.12 (t, J ) 7.3 Hz, 2 H), 7.40-7.49 (m, 3 H), 8.33-
8.38 (m, 4 H), 9.59 (s, 2 H), 9.75 (s, 2 H), 10.33 (s, 2 H). 13C
NMR (CDCl3): δ 56.1, 56.3, 56.5, 64.2, 95.5, 111.4, 115.4, 120.6,
121.5, 121.6, 122.2, 125.4, 128.2, 132.7, 132.8, 135.3, 146.0,
146.1, 155.9, 157.3, 162.2, 162.6. IR (CHCl3): ν 3335, 1615,
1599, 1542, 1459, 1233, 1199, 909, 753 cm-1. MS (ESI): m/z
765 [M + H]+. Anal. Calcd for C41H40N4O11‚H2O: C, 62.94; H,
5.42; N, 7.16. Found: C, 62.78; H, 4.93; N, 6.91. Compound
11: 1H NMR (CDCl3): δ 3.65 (s, 2 H), 3.88 (s, 3 H), 3.93 (s, 3
H), 3.96 (s, 3 H), 3.97 (s, 3 H), 4.03 (s, 3 H), 4.07 (s, 3 H), 6.55
(s, 1 H), 6.61 (s, 1 H), 7.03 (d, J ) 7.8 Hz, 2 H), 7.10 (t, J ) 7.8
Hz, 2 H), 7.41-7.51 (m, 2 H), 8.10 (s, 1 H), 8.25-8.39 (m, 3
H), 9.55 (s, 1 H), 9.68 (s, 1 H), 9.96 (s, 1 H), 10.32 (s, 1 H). 13C
NMR (CDCl3): δ 56.0, 56.1, 56.2, 56.5, 56.9, 64.1, 95.5, 97.1,
108.7, 111.4, 115.4, 120.5, 121.4, 121.5, 121.7, 122.3, 125.4,
128.0, 128.4,129.8, 132.6, 132.8, 134.8, 135.3, 141.8, 143.6,
145.9, 146.1, 155.8,157.3, 162.0, 162.1, 162.6. IR (CHCl3): ν
3321, 1734, 1669, 1553 cm-1. MS (ESI): m/z 630 [M + H]+.
Anal. Calcd for C33H34N4O9: C, 62.85; H, 5.43; N, 8.88.
Found: C, 62.16; H, 5.74; N, 8.15.
N,N′-Bis[2,4-dim eth oxy-5-[2-m eth oxy-3-[2,4-dim eth oxy-
5-(2-m et h oxyb en zoyla m in o)b en zoyla m in o]]p h en yl]-2-
m eth oxyisop h th a la m id e (4). This compound was prepared
from 9 (50 mg, 0.25 mmol) and 11 (0.32 g, 0.5 mmol) on the
N-(5-Am in o-2,4-d im et h oxyp h en yl)-2-m et h oxyb en za -
m id e (12). A solution of compounds 5 (1.68 g, 10.0 mmol), 6
(1.70 g, 10.0 mmol), and triethylamine (2 mL) in dichlo-
(20) Naito, T.; Kuroda, E.; Miyata, O.; Ninomiya, I. Chem. Pharm.
Bull. 1991, 39, 2216.
6226 J . Org. Chem., Vol. 69, No. 19, 2004